Cargando…

Regioselective biooxidation of (+)-valencene by recombinant E. coli expressing CYP109B1 from Bacillus subtilis in a two-liquid-phase system

BACKGROUND: (+)-Nootkatone (4) is a high added-value compound found in grapefruit juice. Allylic oxidation of the sesquiterpene (+)-valencene (1) provides an attractive route to this sought-after flavoring. So far, chemical methods to produce (+)-nootkatone (4) from (+)-valencene (1) involve unsafe...

Descripción completa

Detalles Bibliográficos
Autores principales: Girhard, Marco, Machida, Kazuhiro, Itoh, Masashi, Schmid, Rolf D, Arisawa, Akira, Urlacher, Vlada B
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717049/
https://www.ncbi.nlm.nih.gov/pubmed/19591681
http://dx.doi.org/10.1186/1475-2859-8-36
_version_ 1782169854015438848
author Girhard, Marco
Machida, Kazuhiro
Itoh, Masashi
Schmid, Rolf D
Arisawa, Akira
Urlacher, Vlada B
author_facet Girhard, Marco
Machida, Kazuhiro
Itoh, Masashi
Schmid, Rolf D
Arisawa, Akira
Urlacher, Vlada B
author_sort Girhard, Marco
collection PubMed
description BACKGROUND: (+)-Nootkatone (4) is a high added-value compound found in grapefruit juice. Allylic oxidation of the sesquiterpene (+)-valencene (1) provides an attractive route to this sought-after flavoring. So far, chemical methods to produce (+)-nootkatone (4) from (+)-valencene (1) involve unsafe toxic compounds, whereas several biotechnological approaches applied yield large amounts of undesirable byproducts. In the present work 125 cytochrome P450 enzymes from bacteria were tested for regioselective oxidation of (+)-valencene (1) at allylic C2-position to produce (+)-nootkatone (4) via cis- (2) or trans-nootkatol (3). The P450 activity was supported by the co-expression of putidaredoxin reductase (PdR) and putidaredoxin (Pdx) from Pseudomonas putida in Escherichia coli. RESULTS: Addressing the whole-cell system, the cytochrome CYP109B1 from Bacillus subtilis was found to catalyze the oxidation of (+)-valencene (1) yielding nootkatol (2 and 3) and (+)-nootkatone (4). However, when the in vivo biooxidation of (+)-valencene (1) with CYP109B1 was carried out in an aqueous milieu, a number of undesired multi-oxygenated products has also been observed accounting for approximately 35% of the total product. The formation of these byproducts was significantly reduced when aqueous-organic two-liquid-phase systems with four water immiscible organic solvents – isooctane, n-octane, dodecane or hexadecane – were set up, resulting in accumulation of nootkatol (2 and 3) and (+)-nootkatone (4) of up to 97% of the total product. The best productivity of 120 mg l(-1 )of desired products was achieved within 8 h in the system comprising 10% dodecane. CONCLUSION: This study demonstrates that the identification of new P450s capable of producing valuable compounds can basically be achieved by screening of recombinant P450 libraries. The biphasic reaction system described in this work presents an attractive way for the production of (+)-nootkatone (4), as it is safe and can easily be controlled and scaled up.
format Text
id pubmed-2717049
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27170492009-07-29 Regioselective biooxidation of (+)-valencene by recombinant E. coli expressing CYP109B1 from Bacillus subtilis in a two-liquid-phase system Girhard, Marco Machida, Kazuhiro Itoh, Masashi Schmid, Rolf D Arisawa, Akira Urlacher, Vlada B Microb Cell Fact Research BACKGROUND: (+)-Nootkatone (4) is a high added-value compound found in grapefruit juice. Allylic oxidation of the sesquiterpene (+)-valencene (1) provides an attractive route to this sought-after flavoring. So far, chemical methods to produce (+)-nootkatone (4) from (+)-valencene (1) involve unsafe toxic compounds, whereas several biotechnological approaches applied yield large amounts of undesirable byproducts. In the present work 125 cytochrome P450 enzymes from bacteria were tested for regioselective oxidation of (+)-valencene (1) at allylic C2-position to produce (+)-nootkatone (4) via cis- (2) or trans-nootkatol (3). The P450 activity was supported by the co-expression of putidaredoxin reductase (PdR) and putidaredoxin (Pdx) from Pseudomonas putida in Escherichia coli. RESULTS: Addressing the whole-cell system, the cytochrome CYP109B1 from Bacillus subtilis was found to catalyze the oxidation of (+)-valencene (1) yielding nootkatol (2 and 3) and (+)-nootkatone (4). However, when the in vivo biooxidation of (+)-valencene (1) with CYP109B1 was carried out in an aqueous milieu, a number of undesired multi-oxygenated products has also been observed accounting for approximately 35% of the total product. The formation of these byproducts was significantly reduced when aqueous-organic two-liquid-phase systems with four water immiscible organic solvents – isooctane, n-octane, dodecane or hexadecane – were set up, resulting in accumulation of nootkatol (2 and 3) and (+)-nootkatone (4) of up to 97% of the total product. The best productivity of 120 mg l(-1 )of desired products was achieved within 8 h in the system comprising 10% dodecane. CONCLUSION: This study demonstrates that the identification of new P450s capable of producing valuable compounds can basically be achieved by screening of recombinant P450 libraries. The biphasic reaction system described in this work presents an attractive way for the production of (+)-nootkatone (4), as it is safe and can easily be controlled and scaled up. BioMed Central 2009-07-10 /pmc/articles/PMC2717049/ /pubmed/19591681 http://dx.doi.org/10.1186/1475-2859-8-36 Text en Copyright © 2009 Girhard et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Girhard, Marco
Machida, Kazuhiro
Itoh, Masashi
Schmid, Rolf D
Arisawa, Akira
Urlacher, Vlada B
Regioselective biooxidation of (+)-valencene by recombinant E. coli expressing CYP109B1 from Bacillus subtilis in a two-liquid-phase system
title Regioselective biooxidation of (+)-valencene by recombinant E. coli expressing CYP109B1 from Bacillus subtilis in a two-liquid-phase system
title_full Regioselective biooxidation of (+)-valencene by recombinant E. coli expressing CYP109B1 from Bacillus subtilis in a two-liquid-phase system
title_fullStr Regioselective biooxidation of (+)-valencene by recombinant E. coli expressing CYP109B1 from Bacillus subtilis in a two-liquid-phase system
title_full_unstemmed Regioselective biooxidation of (+)-valencene by recombinant E. coli expressing CYP109B1 from Bacillus subtilis in a two-liquid-phase system
title_short Regioselective biooxidation of (+)-valencene by recombinant E. coli expressing CYP109B1 from Bacillus subtilis in a two-liquid-phase system
title_sort regioselective biooxidation of (+)-valencene by recombinant e. coli expressing cyp109b1 from bacillus subtilis in a two-liquid-phase system
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717049/
https://www.ncbi.nlm.nih.gov/pubmed/19591681
http://dx.doi.org/10.1186/1475-2859-8-36
work_keys_str_mv AT girhardmarco regioselectivebiooxidationofvalencenebyrecombinantecoliexpressingcyp109b1frombacillussubtilisinatwoliquidphasesystem
AT machidakazuhiro regioselectivebiooxidationofvalencenebyrecombinantecoliexpressingcyp109b1frombacillussubtilisinatwoliquidphasesystem
AT itohmasashi regioselectivebiooxidationofvalencenebyrecombinantecoliexpressingcyp109b1frombacillussubtilisinatwoliquidphasesystem
AT schmidrolfd regioselectivebiooxidationofvalencenebyrecombinantecoliexpressingcyp109b1frombacillussubtilisinatwoliquidphasesystem
AT arisawaakira regioselectivebiooxidationofvalencenebyrecombinantecoliexpressingcyp109b1frombacillussubtilisinatwoliquidphasesystem
AT urlachervladab regioselectivebiooxidationofvalencenebyrecombinantecoliexpressingcyp109b1frombacillussubtilisinatwoliquidphasesystem